Yang KD - Search Results

1

Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization.

Li Z, Fu WJ, Chen XQ, Wang S, Deng RS, Tang XP, Yang KD, Niu Q, Zhou H, Li QR, Lin Y, Liang M, Li SS, Ping YF, Liu XD, Bian XW, Yao XH. Li Z, et al. Among authors: yang kd. J Exp Clin Cancer Res. 2022 Feb 22;41(1):74. doi: 10.1186/s13046-022-02291-8. J Exp Clin Cancer Res. 2022. PMID: 35193644 Free PMC article.

2

A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.

Chen C, Shi Y, Li Y, He ZC, Zhou K, Zhang XN, Yang KD, Wu JR, Kung HF, Ping YF, Bian XW. Chen C, et al. Among authors: yang kd. J Genet Genomics. 2017 Nov 20;44(11):519-530. doi: 10.1016/j.jgg.2017.05.007. Epub 2017 Sep 21. J Genet Genomics. 2017. PMID: 29169920

3

VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.

Zhou K, Yao YL, He ZC, Chen C, Zhang XN, Yang KD, Liu YQ, Liu Q, Fu WJ, Chen YP, Niu Q, Ma QH, Zhou R, Yao XH, Zhang X, Cui YH, Bian XW, Shi Y, Ping YF. Zhou K, et al. Among authors: yang kd. Cell Death Dis. 2018 Sep 24;9(10):988. doi: 10.1038/s41419-018-1015-x. Cell Death Dis. 2018. PMID: 30250190 Free PMC article.

4

A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses.

Cao M, Cai J, Yuan Y, Shi Y, Wu H, Liu Q, Yao Y, Chen L, Dang W, Zhang X, Xiao J, Yang K, He Z, Yao X, Cui Y, Zhang X, Bian X. Cao M, et al. Cancer Biol Med. 2019 Aug;16(3):595-605. doi: 10.20892/j.issn.2095-3941.2018.0277. Cancer Biol Med. 2019. PMID: 31565488 Free PMC article.

5

Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.

Wen XM, Luo T, Jiang Y, Wang LH, Luo Y, Chen Q, Yang K, Yuan Y, Luo C, Zhang X, Yan ZX, Fu WJ, Tan YH, Niu Q, Xiao JF, Chen L, Wang J, Huang JF, Cui YH, Zhang X, Wang Y, Bian XW. Wen XM, et al. Lab Invest. 2020 Jun;100(6):812-823. doi: 10.1038/s41374-019-0368-9. Epub 2020 Jan 16. Lab Invest. 2020. PMID: 31949244 Free article.

6

Nanog promotes stem-like traits of glioblastoma cells.

Yuan Y, Zhang M, Yan G, Ma Q, Yan Z, Wang L, Yang K, Guo D. Yuan Y, et al. Front Biosci (Landmark Ed). 2021 Jan 1;26(3):552-565. doi: 10.2741/4907. Front Biosci (Landmark Ed). 2021. PMID: 33049683 Free article.

7

Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling.

Zhang XN, Yang KD, Chen C, He ZC, Wang QH, Feng H, Lv SQ, Wang Y, Mao M, Liu Q, Tan YY, Wang WY, Li TR, Che LR, Qin ZY, Wu LX, Luo M, Luo CH, Liu YQ, Yin W, Wang C, Guo HT, Li QR, Wang B, Chen W, Wang S, Shi Y, Bian XW, Ping YF. Zhang XN, et al. Among authors: yang kd. Cell Res. 2021 Oct;31(10):1072-1087. doi: 10.1038/s41422-021-00528-3. Epub 2021 Jul 8. Cell Res. 2021. PMID: 34239070 Free PMC article.

8

Overexpression of carnitine palmitoyltransferase 1A promotes mitochondrial fusion and differentiation of glioblastoma stem cells.

Luo M, Liu YQ, Zhang H, Luo CH, Liu Q, Wang WY, He ZC, Chen C, Zhang XN, Mao M, Yang KD, Wang C, Chen XQ, Fu WJ, Niu Q, Bian XW, Shi Y, Ping YF. Luo M, et al. Among authors: yang kd. Lab Invest. 2022 Jul;102(7):722-730. doi: 10.1038/s41374-021-00724-0. Epub 2021 Dec 28. Lab Invest. 2022. PMID: 34963686 Free article.

9

Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma.

Yang K, Shi Y, Luo M, Mao M, Zhang X, Chen C, Liu Y, He Z, Liu Q, Wang W, Luo C, Yin W, Wang C, Niu Q, Zeng H, Bian XW, Ping YF. Yang K, et al. Oncoimmunology. 2022 Jan 26;11(1):2030020. doi: 10.1080/2162402X.2022.2030020. eCollection 2022. Oncoimmunology. 2022. PMID: 35096487 Free PMC article.

10

HOXA5 is amplified in glioblastoma stem cells and promotes tumor progression by transcriptionally activating PTPRZ1.

He ZC, Liu Q, Yang KD, Chen C, Zhang XN, Wang WY, Zeng H, Wang B, Liu YQ, Luo M, Li L, Niu Q, Lu HM, Luo T, Yao XH, Guo HT, Ji JL, Cao MF, Shi Y, Ping YF, Bian XW. He ZC, et al. Among authors: yang kd. Cancer Lett. 2022 May 1;533:215605. doi: 10.1016/j.canlet.2022.215605. Epub 2022 Feb 24. Cancer Lett. 2022. PMID: 35219772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page